文献速递腹部MR

钆塞酸二钠增强MRI对壶腹周围癌患者肝微脓肿与肝转移瘤的鉴别价值

The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
PubMed 文献 · Eur Radiol · 2017-03-24

研究纳入72例壶腹周围癌患者(31例共83个肝微脓肿,41例共71个肝转移瘤),分析钆塞酸二钠增强MRI征象。多因素分析显示,胆管癌病史、病灶周围充血、动脉期边缘强化持续至移行期、T1WI与T2WI及T1WI与肝胆期图像间大小差异为微脓肿的显著参数。当T1WI与肝胆期图像大小差异≥30%或动脉期边缘强化持续至移行期时,诊断准确率最高达90.9%;两者均阳性时特异度达100%。

要点

  • T1WI与肝胆期图像大小差异≥30%或动脉期边缘强化持续至移行期时,肝微脓肿诊断准确率最高达90.9%。
  • 上述两项征象同时阳性时,鉴别肝微脓肿与转移瘤的特异度达100%。
  • 胆管癌病史、病灶周围充血、T1WI与T2WI间大小差异也有助于提示肝微脓肿。

核心结论

  • T1WI与肝胆期图像间大小差异联合动脉期边缘强化持续至移行期,是鉴别壶腹周围癌患者肝微脓肿与肝转移瘤的可靠MRI特征。

研究设计与样本

  • 回顾性纳入72例有壶腹周围癌病史并接受钆塞酸二钠增强MRI的患者,其中31例共83个肝微脓肿、41例共71个肝转移瘤;由两名观察者共识进行图像分析。

关键影像表现/征象

  • 肝微脓肿在T1WI与T2WI之间、T1WI与肝胆期图像之间显示大小差异。
  • 肝微脓肿表现为动脉期边缘强化并持续至移行期。
  • 肝微脓肿可见病灶周围充血。

诊断标准与关键数值

  • T1WI与肝胆期图像大小差异≥30%或动脉期边缘强化持续至移行期时,肝微脓肿诊断准确率最高为90.9%。
  • 上述两项变量同时阳性时,特异度达100%。
  • 多因素分析中提示微脓肿的显著参数包括胆管癌病史、病灶周围充血、动脉期边缘强化持续至移行期、T1WI与T2WI间大小差异、T1WI与肝胆期图像间大小差异。

临床应用与阅片要点

  • 阅片时可关注T1WI与肝胆期图像间病灶大小差异是否≥30%,以及动脉期边缘强化是否持续至移行期。
  • 两项征象同时阳性时提示肝微脓肿可能,原文报告其特异度达100%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We aimed to identify features that differentiate hepatic microabscess from hepatic metastasis on gadoxetic acid-enhanced MRI in patients with periampullary cancer.

METHODS: We included 72 patients (31 patients with 83 hepatic microabscesses and 41 patients with 71 hepatic metastases) who had a history of periampullary cancer and underwent gadoxetic acid-enhanced MRI. Image analysis was performed for margin, signal intensity, rim enhancement, perilesional hyperaemia, pattern on DWI and dynamic phases, and size discrepancy between sequences by consensus of two observers.

RESULTS: Multivariate analysis revealed that the following significant parameters favour microabscess: a history of bile duct cancer, perilesional hyperaemia, persistent arterial rim enhancement through the transitional phase (TP), and size discrepancy between T1WI and T2WI and between T1WI and hepatobiliary phase image (HBPI). The diagnostic accuracy for microabscess was highest (90.9%) when showing a size discrepancy ≥30% between T1WI and HBPI or persistent arterial rim enhancement through the TP. When the lesion was positive for both these variables, specificity reached 100%.

CONCLUSION: The combination of a size discrepancy between T1WI and HBPI and persistent arterial rim enhancement through the TP represents a reliable MRI feature for distinguishing between hepatic microabscess and metastasis in patients with periampullary cancer.

KEY POINTS: • Gadoxetic acid-enhanced MRI is useful for distinguishing hepatic microabscess from metastasis. • Hepatic microabscess showed significant size discrepancy ≥30% between T1WI and HBPI. • Arterial rim enhancement persistent through the TP indicates hepatic microabscess.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Choi SY, Kim YK, Min JH, et al. The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer. Eur Radiol. 2017. PMID: 28342102. doi:10.1007/s00330-017-4782-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。